China SXT Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -35.7% | -35.7% | -17.1% |
| FY2023 | -40.4% | -40.1% | -20.1% |
| FY2024 | -22.2% | -22.1% | -13.4% |
| FY2025 | -21.4% | -21.3% | -15.2% |
| FY2026 | -20.9% | -20.4% | -17.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -35.7% | -35.7% | -17.1% |
| FY2023 | -40.4% | -40.1% | -20.1% |
| FY2024 | -22.2% | -22.1% | -13.4% |
| FY2025 | -21.4% | -21.3% | -15.2% |
| FY2026 | -20.9% | -20.4% | -17.9% |